Bioventure

Bioventure is a Chinese venture capital firm specializing in early and growth stage investments in the life sciences sector. The firm focuses on biotechnology, medical devices, healthcare services, and pharmaceuticals, aiming to support innovative companies with high growth potential. Bioventure provides capital and post-investment support to help these companies achieve rapid growth and success.

Established in September 2013, Bioventure has a fund size of 540 million yuan and is backed by Suzhou Industrial Park and BioBay. The firm is committed to becoming one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. Bioventure's team consists of senior investment professionals with deep knowledge of domestic and foreign markets, enabling them to assist companies in navigating the complexities of the life sciences industry.

Through joint venture development cooperation, Bioventure seeks to drive innovation and growth in the medical and pharmaceutical industry. The firm's investment strategy includes in-licensing innovative products and technologies to address unmet medical needs in the growing Chinese market. By creating new companies with entrepreneurs and global partners, Bioventure aims to bring global technologies to China quickly and efficiently, contributing to the advancement of healthcare solutions in the region.